Illinois Attorney General Lisa Madigan has reached a $4.5 million settlement with an Arizona-based pharmaceutical company that her office sued for deceptive marketing of an opioid drug meant for cancer patients.
Madigan said Insys Therapeutics Inc. “pushed a highly addictive opioid in complete disregard for patients’ health to increase company profits.”
The lawsuit she filed last year accused Insys of selling Subsys, a drug significantly more powerful than morphine, to treat a wide variety of pain such as back and neck pain. The drug was not approved for those uses.
Insys officials didn’t respond to phone messages left by the Associated Press at the company’s Phoenix-area office. The company has previously said the marketing of Subsys was appropriate.
Madigan says the $4.5 million will fund drug treatment programs.
Topics Illinois
Was this article valuable?
Here are more articles you may enjoy.
Rivian Agrees to Pay $250 Million to Settle IPO Fraud Lawsuit 
AIG to Acquire Renewal Rights of Everest’s Retail Commercial Business Worth $2B 
Best Agency to Work For – Overall Winner: Robertson Ryan Insurance 
Alaska Airlines Vows IT Upgrades After Outage Forces 400 Flight Cancellations 
